• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Emilio Franzoni, Stefano Gualandi, +7 authors Alessandro Pellicciari
  • Medicine
  • Neuropsychiatric disease and treatment
  • 2013 (First Published: 1 February 2013)
  • BACKGROUND The connections between eating disorders (EDs) and alexithymia have not been fully clarified. This study aims to define alexithymia's connections with shame, trauma, dissociation, and bodyContinue Reading
  • Beatrice Salvioli, Alessandro Pellicciari, +7 authors Emilio Franzoni
  • Medicine
  • Digestive and liver disease : official journal of…
  • 2013 (First Published: 1 August 2013)
  • BACKGROUND Esophago-gastrointestinal symptoms are frequently reported by patients with eating disorders. Scanty data exist on the relationship between psychopathological traits and digestiveContinue Reading
  • Alessandro Pellicciari, Francesca Rossi, Luisa Iero, Elena Di Pietro, Alberto Verrotti, Emilio Franzoni
  • Medicine
  • Journal of alternative and complementary medicine
  • 2013 (First Published: 1 July 2013)
  • OBJECTIVES The authors present a description of a theater workshop ("Metamorphosis Project"), developed at the Bologna Eating Disorders Center. DESIGN The workshops are aimed at young, hospitalizedContinue Reading
  • E. Franzoni, Morena Monti, +8 authors Paola Gualandi
  • Medicine
  • Neuropsychiatric disease and treatment
  • 2009 (First Published: 1 March 2009)
  • In order to evaluate the psychiatric symptoms associated with a diagnosis of eating disorders (ED) we have administered a new psychometric instument: the Self Administrated Psychiatric Scales forContinue Reading
  • Alessandro Pellicciari, Beatrice Balzarro, Annarosa Scaramelli, Stefano Porcelli, Alessandro Serretti, Diana De Ronchi
  • Biology, Medicine
  • Neurotoxicology
  • 2012 (First Published: 1 March 2012)
  • Duloxetine is a potent and selective inhibitor of serotonin and norepinephrine reuptake (SNRI) with a weak activity over dopamine reuptake used in the treatment of major depressive disorder. DailyContinue Reading